Ketamine Troche Dosage: A Patient Reference Guide

Most patients searching for ketamine troche dosage want one thing: a clear sense of what range their prescription is likely to land in, and what those numbers actually mean. This reference focuses on sublingual lozenges (troches) used in low-dose maintenance protocols. It is not a substitute for your own prescription label or for dosing instructions from a licensed clinician.

What a Ketamine Troche Actually Is

A ketamine troche is a compounded lozenge made by a pharmacy to a prescriber's specification, typically holding a fixed milligram strength of racemic ketamine in a flavored base. Troches are designed to dissolve slowly under the tongue or against the cheek so part of the dose absorbs through the oral mucosa, with the rest swallowed and absorbed through the gut. The sublingual fraction reaches the bloodstream more efficiently than the swallowed fraction because it partially bypasses first-pass liver metabolism.

Because troches are compounded rather than FDA-approved off-the-shelf products, strengths vary by pharmacy and prescription. The figure on the label is the milligram content per troche, not a guaranteed blood level — bioavailability depends on technique and individual physiology.

Typical Dose Ranges in Maintenance Protocols

Most published sublingual maintenance protocols cluster in the 50-150 mg range per session, with starting doses often at the lower end and incremental upward titration based on tolerability and response. Some patients stabilize on 50-75 mg; others sit at 100-150 mg; a smaller subset uses 200 mg or more under clinician supervision. The dose is individual — body weight, prior ketamine exposure, indication, and concurrent medications all shape it.

Frequency is also part of the dose picture. A patient at 100 mg twice weekly is on a meaningfully different total exposure than one at 100 mg every two weeks. Discussions about dose should always include frequency, not just per-session milligrams.

How Troches Are Taken: Technique Matters

Two patients given identical 100 mg troches can experience meaningfully different effects depending on how they take them. The intended technique is to let the lozenge dissolve slowly under the tongue or in the cheek pouch — typically over 7-15 minutes — without chewing, without sipping water, and without swallowing the saliva early. This holds more of the dose in contact with the oral mucosa, raising the sublingual absorption fraction. The remaining liquid is swallowed at the end.

Swallowing too early shifts more of the dose into the gut, where first-pass metabolism reduces what reaches the bloodstream as ketamine. Patients sometimes describe weaker effects from one session and stronger effects from the next purely because of technique variation.

A Patient Checklist Before Each Troche Session

1. Confirm the strength on the label and the number of troches your prescription says to take.
2. Do not eat or drink in the 30 minutes before dosing — food residue and saliva volume change absorption.
3. Set a quiet, safe space with an adult support person if your prescriber asked you to have one.
4. Let the troche fully dissolve in your mouth (typically 7-15 minutes) before swallowing the residue.
5. Record dose, time, effect intensity, and any side effects in your tracking log immediately after the session.
6. Avoid driving, machinery, or major decisions until the prescribed recovery window has fully passed.

How Prescribers Adjust the Dose

Most adjustments are made in small increments — commonly 25 mg or 50 mg steps — based on symptom response, tolerability, and side-effect profile. Prescribers tend to move slowly upward and pull back quickly if dissociation, blood pressure changes, nausea, or unwanted psychiatric effects appear. A long, stable course at 75-100 mg is often a better outcome than chasing an ever-higher dose in search of a stronger effect.

Patients sometimes assume a stronger dissociative experience equals better treatment. The clinical evidence does not support that. Symptom improvement on validated scales matters more than how vivid a given session felt.

Safety, Contraindications, and Hard Limits

Sublingual ketamine is not appropriate for everyone. Uncontrolled hypertension, recent cardiovascular events, severe liver disease, untreated psychotic disorders, active substance use disorder involving sedatives, pregnancy, and breastfeeding are common reasons to avoid or pause treatment. Combinations with benzodiazepines, opioids, Z-drugs, alcohol, or recreational sedatives raise sedation and respiratory risk and should never be self-stacked.

Bladder and urinary symptoms — frequency, urgency, pain — are a documented concern with higher chronic ketamine exposure and should be reported immediately. Cognitive concerns, mood changes, or worsening psychiatric symptoms warrant a prompt clinician review rather than a self-adjusted dose. Driving and operating machinery should wait for the full recovery window your prescriber set, every time, regardless of how mild a session felt.

If anything about your dose, timing, or response feels off, the right step is a conversation with the licensed clinician who wrote the prescription — not a search for a higher number online.